Biote Corp (BTMD)
6.14
+0.08
(+1.32%)
USD |
NASDAQ |
Nov 21, 16:00
6.13
-0.01
(-0.16%)
After-Hours: 20:00
Biote Revenue (Quarterly): 51.38M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 51.38M |
| June 30, 2024 | 49.17M |
| March 31, 2024 | 46.80M |
| December 31, 2023 | 45.70M |
| September 30, 2023 | 45.56M |
| June 30, 2023 | 49.26M |
| March 31, 2023 | 44.84M |
| Date | Value |
|---|---|
| December 31, 2022 | 44.48M |
| September 30, 2022 | 41.97M |
| June 30, 2022 | 41.36M |
| March 31, 2022 | 37.14M |
| December 31, 2021 | 37.54M |
| September 30, 2021 | 35.57M |
| June 30, 2021 | 34.75M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
34.75M
Minimum
Jun 2021
51.38M
Maximum
Sep 2024
43.25M
Average
44.66M
Median
Revenue (Quarterly) Benchmarks
| American Shared Hospital Services | 6.999M |
| Omnicell Inc | 282.42M |
| Astrana Health Inc | 478.71M |
| Cryo-Cell International Inc | 8.067M |
| P3 Health Partners Inc | 362.12M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 10.70M |
| Total Expenses (Quarterly) | 39.20M |
| EPS Diluted (Quarterly) | 0.33 |
| Enterprise Value | 275.12M |
| Gross Profit Margin (Quarterly) | 70.47% |
| Profit Margin (Quarterly) | 20.83% |
| Earnings Yield | 4.23% |
| Operating Earnings Yield | 16.70% |
| Normalized Earnings Yield | 9.219 |